90686 Ndc Code 2024. The product was first marketed by sanofi pasteur inc. 90686, “influenza virus vaccine, quadrivalent (iiv4), split virus, preservative free, 0.5 ml dosage, for intramuscular.
The new codes are effective for dates. Different package codes only differentiate between different quantitative and qualitative attributes of the product.
26, 2023, Medicare Administrative Contractors Began Issuing Notices Of These Code Changes With Pricing Information.
The purpose of the ndc crosswalk tables is to show the relationships of vaccine primary and secondary packaging ndcs and provide related information for use as reference data for.
Influenza Virus Vaccine, Quadrivalent, Split Virus, Preservative Free, When Administered To Individuals 3 Years Of Age And Older, For Intramuscular Use:
Different package codes only differentiate between different quantitative and qualitative attributes of the product.